PA-GECKO-ROBOTICS
13.10.2022 11:01:49 CEST | Business Wire | Press release
Gecko Robotics, a leader in using advanced robotics and enterprise software to help ensure the availability, reliability and sustainability of critical infrastructure, today announced a three-year collaboration with Siemens Energy’s European Field Service organization to market and perform advanced ultrasonic robotic inspections services across Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221013005396/en/
Gecko builds wall-climbing robots and enterprise software to protect the infrastructure of daily life. At a time of massive disruptions and surging demand, Gecko’s technology is helping to maximize the productivity, reliability and longevity of the assets that underpin essential industries including power generation, oil & gas refining, heavy manufacturing, transportation and more. (Photo: Business Wire)
These advanced robotic inspections are poised to strengthen critical infrastructure and transform how installed equipment is inspected and maintained. Together, the two companies will develop new technologies and services to better serve customers across several industries, including pulp & paper, power generation (conventional and renewable) and oil & gas.
"Over the past year, we've worked closely with experts from Siemens Energy to understand the value and impact that the collaboration of our companies can create for the European energy market,” noted Ryan Herman, Gecko’s Managing Director, Europe. “It’s become clear that by coming together to serve these customers we can unlock new data insights and help achieve reliability and efficiency not previously possible.”
Ultrasonic Robots Will Bring Unparalleled Advantages to European Customers
Siemens Energy’s European Field Service organization and Gecko Robotics have already completed inspections across Europe in Poland (pulp/paper), Belgium (waste to energy), the Netherlands (food processing) and the UK (power generation). In support of the collaboration, Siemens Energy has established a new Product Competence Center in the Netherlands, with expansion plans underway.
"The collaboration between Gecko Robotics and Siemens Energy brings the best of both worlds together to deliver end-to-end value for our customers. With one of the industry’s largest installed fleets of rotating equipment, Siemens Energy will provide unparalleled customer access to bring proven robotics technology to its wide customer base,” according to Herman Smit, Manager Robotic Inspections at Siemens Energy. “The robotic inspection system will not only ensure safe and reliable operations of customer assets but also provide rich multi-modal data to make condition-based maintenance of static equipment much more feasible."
Gecko Robotics’ robots are remote controlled and equipped with ultrasonic transducers, localization sensors, lasers and HD cameras. They climb vertically and horizontally, adhering magnetically to an extensive range of equipment types to scan for changes in thickness, cracks, corrosion, blistering and other forms of degradation. The robots also include localization technology to pinpoint exact locations on an asset, allowing for truly accurate inspections that enable inspectors to examine corrosion trends over time, predict when failures will occur and estimate when repairs will be necessary.
Data captured by Gecko’s robots and its software platform can then produce a validated report within 24 hours, allowing inspectors to quickly assess and make informed decisions about ongoing maintenance or repairs. This process and quick turnaround also enable inspectors to reduce asset downtime and lost production, while ensuring critical repairs are conducted with high confidence.
By aligning with Siemens Energy’s European Field Service organization, Gecko gains a local presence across Europe, access to local technical talent and the opportunity to work with customers in the region. Siemens Energy will be responsible for hiring and training local technicians and customer service personnel across Europe, allowing Gecko Robotics to efficiently deliver state-of-the-art technology, while adhering to all local safety and labor regulations.
About Gecko Robotics:
Gecko builds wall-climbing robots and enterprise software to protect the infrastructure of daily life. At a time of massive disruptions and surging demand, Gecko’s technology is helping to maximize the productivity, reliability and longevity of the assets that underpin essential industries including power generation, oil & gas refining, heavy manufacturing, transportation and more. Gecko’s robots capture data at orders of magnitude greater scale and fidelity than traditional, manual inspection methods. Combined with Gecko’s software, this data magnifies the contributions of human experts while eliminating the need to enter dangerous areas themselves. This results in optimized maintenance, greater uptime, informed CAPEX investment, significant cost savings, lower environmental footprints and fewer workplace injuries. www.geckorobotics.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221013005396/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
Unpack ’26 sommerrejsetrends: Flere vælger indenlandske rejser, når de tænker mere bevidst over deres rejsevalg21.5.2026 12:35:00 CEST | Pressemeddelelse
Rejsebranchens førende databrevne trendrapport lancerer sin første sommerudgave nogensinde – Unpack ’26 Summer: The Trends in Travel I dag har Hotels.com udgivet Unpack ’26 Summer: The Trends in Travel, den nyeste udgave af virksomhedens førende trendrapport i rejsebranchen, som viser, hvordan rejseadfærd former sommerens rejsevalg. Efterspørgslen på indenlandske rejser præger sommerens ferieplanlægning. Interessen på sociale medier for indenlandske ferier er globalt steget med 77% sammenlignet med sidste år, og 44% af danske rejsende planlægger en indenlandsk rejse denne sommer*. Fra store sportsbegivenheder og koncerter til rejser inspireret af film og tv bygger Unpack ’26 Summer på indsigter fra den årlige hovedrapport Unpack ’26: The Trends in Travel™ for at fremhæve, hvor rejsende tager hen denne sommer. HHver tendens bygger på førstehåndsdata fra Hotels.com® kombineret med indsigter fra rejsende og overvågning af sociale medier. “Denne sommer bliver der stadig rejst – men på nye
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 12:30:00 CEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un
Cognite and ABB Collaborate to Integrate Agentic AI into Industrial Applications to Deliver Faster Workflows21.5.2026 12:00:00 CEST | Press release
Aker BP joins as the first customer to scale agent-to-agent operations through a new generation of industrial agentic workflow applications Cognite, the leader in Industrial AI, today announced a collaboration with ABB to assess how advanced industrial AI and data capabilities can be integrated to solve key use cases in the energy sector. By adding an agentic layer to established industrial applications, including ABB Ability™ SafetyInsight™ and ABB Ability™ AlarmInsight™, using the Cognite Industrial AI and Data platform, the collaboration aims to enable "agent-to-agent" orchestration. Leading energy producer Aker BP has signed on as the first customer to implement this new generation of intelligent offerings as part of its strategy to further increase its current production efficiency of 96% and achieve a production growth target of 525,000 barrels of oil equivalent per day by 2028. Transforming Data into Actionable Business Value By breaking down traditional data silos and shifting
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts21.5.2026 12:00:00 CEST | Press release
Long-term and real-world evidence reinforce BRUKINSA as the foundation of CLL treatmentThree oral presentations at ASCO highlight rapid acceleration of BeOne’s solid tumor pipeline BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that more than 60 abstracts across hematologic malignancies and solid tumors have been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (May 29–June 2, Chicago) and the 2026 European Hematology Association (EHA) Congress (June 11–14, Stockholm). Continuing to raise the bar in CLL At ASCO and EHA 2026, BeOne will showcase its hematology leadership with data spanning foundational therapies and next-generation innovation across CLL, mantle cell lymphoma and other B-cell malignancies. The data emphasize impressive long-term outcomes, durability across patient populations, and a disciplined approach to advancing future regimens. Collectively, these data undersco
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
